Form 4: Applied Therapeutics CFO Sells Shares to Cover Tax Obligations

Leslie D. Funtleyder, CFO of Applied Therapeutics, Inc., sold 13,530 shares of common stock on August 22, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On August 22, 2024, Leslie D. Funtleyder, the Chief Financial Officer of Applied Therapeutics, Inc. (APLT), sold 13,530 shares of the company's common stock.
• The shares were sold at a price of $5.83 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units (RSUs).
• Following the transaction, Funtleyder directly owns 277,911 shares of Applied Therapeutics, Inc.

Sentiment

Score: 6

Explanation: The document is neutral. It simply reports a stock sale to cover tax obligations, which is a common practice. There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, covering tax obligations, and doesn't necessarily indicate a change in the CFO's long-term outlook on the company.

Stakeholder Impact

• The sale of shares by an insider could be perceived negatively by some shareholders, but the explanation provided (covering tax obligations) mitigates this concern.

Key Dates